(ATEC) Alphatec Holdings - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US02081G2012

Spine Screw, Spacer Rod, Bone Cement, Surgical Tools

ATEC EPS (Earnings per Share)

EPS (Earnings per Share) of ATEC over the last years for every Quarter: "2020-09": -0.24, "2020-12": -0.35, "2021-03": -0.26, "2021-06": -0.39, "2021-09": -0.36, "2021-12": -0.4, "2022-03": -0.43, "2022-06": -0.36, "2022-09": -0.35, "2022-12": -0.33, "2023-03": -0.4, "2023-06": -0.43, "2023-09": -0.35, "2023-12": -0.37, "2024-03": -0.34, "2024-06": -0.29, "2024-09": -0.28, "2024-12": -0.0638, "2025-03": -0.0879, "2025-06": 0.02, "2025-09": 0,

ATEC Revenue

Revenue of ATEC over the last years for every Quarter: 2020-09: 41.163, 2020-12: 43.954, 2021-03: 44.121, 2021-06: 62.249, 2021-09: 62.88, 2021-12: 73.962, 2022-03: 70.933, 2022-06: 84.151, 2022-09: 89.839, 2022-12: 105.944, 2023-03: 109.11, 2023-06: 116.92, 2023-09: 118.262, 2023-12: 137.97, 2024-03: 138.477, 2024-06: 145.573, 2024-09: 150.719, 2024-12: 176.793, 2025-03: 169.18, 2025-06: 185.544, 2025-09: null,

Description: ATEC Alphatec Holdings

Alphatec Holdings Inc (NASDAQ:ATEC) is a US-based company operating in the Health Care Equipment sub-industry. The companys quarterly tax provision is being analyzed, suggesting a focus on financial performance and potential tax implications.

To better understand ATECs position, key economic drivers and KPIs should be considered. The healthcare equipment industry is influenced by factors such as government regulations, technological advancements, and demographic changes. ATECs performance is likely tied to the demand for its products, which may be driven by an aging population and an increased need for surgical procedures. Revenue growth, gross margin, and operating expenses as a percentage of revenue are important metrics to monitor.

ATECs market capitalization stands at approximately $2.01 billion, indicating a mid-cap stock. The absence of a reported P/E ratio and forward P/E ratio may be due to negative earnings, which is consistent with the negative Return on Equity (RoE) of -276.58%. This suggests that the company is currently unprofitable. Investors should focus on other metrics such as revenue growth rate, cash flow generation, and operating leverage to assess the companys potential for future profitability.

To evaluate ATECs stock performance, its essential to analyze its price action in relation to industry peers and the broader market. The stocks beta of 1.055 indicates that it is slightly more volatile than the overall market. Investors should consider the companys potential for long-term growth, competitive advantages, and managements ability to execute on strategic initiatives.

ATEC Stock Overview

Market Cap in USD 1,945m
Sub-Industry Health Care Equipment
IPO / Inception 2006-06-02

ATEC Stock Ratings

Growth Rating 50.9%
Fundamental 37.7%
Dividend Rating -
Return 12m vs S&P 500 148%
Analyst Rating 4.30 of 5

ATEC Dividends

Currently no dividends paid

ATEC Growth Ratios

Growth Correlation 3m -8.1%
Growth Correlation 12m 81.3%
Growth Correlation 5y -16.8%
CAGR 5y 15.31%
CAGR/Max DD 3y (Calmar Ratio) 0.21
CAGR/Mean DD 3y (Pain Ratio) 0.52
Sharpe Ratio 12m 0.60
Alpha 152.18
Beta 1.056
Volatility 53.47%
Current Volume 1954k
Average Volume 20d 1809.9k
Stop Loss 14.6 (-5.8%)
Signal 0.52

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (-166.0m TTM) > 0 and > 6% of Revenue (6% = 40.9m TTM)
FCFTA -0.04 (>2.0%) and ΔFCFTA 23.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 42.38% (prev 38.34%; Δ 4.04pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.02 (>3.0%) and CFO 15.7m > Net Income -166.0m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 2.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (149.9m) change vs 12m ago 5.06% (target <= -2.0% for YES)
Gross Margin 68.81% (prev 59.49%; Δ 9.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 87.53% (prev 70.30%; Δ 17.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -3.89 (EBITDA TTM -68.1m / Interest Expense TTM 33.9m) >= 6 (WARN >= 3)

Altman Z'' -6.35

(A) 0.37 = (Total Current Assets 443.3m - Total Current Liabilities 154.2m) / Total Assets 790.3m
(B) -1.74 = Retained Earnings (Balance) -1.37b / Total Assets 790.3m
warn (B) unusual magnitude: -1.74 — check mapping/units
(C) -0.17 = EBIT TTM -131.8m / Avg Total Assets 779.4m
(D) -1.86 = Book Value of Equity -1.38b / Total Liabilities 742.9m
Total Rating: -6.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 37.70

1. Piotroski 3.0pt = -2.0
2. FCF Yield -1.19% = -0.59
3. FCF Margin -4.13% = -1.55
4. Debt/Equity 12.38 = -2.50
5. Debt/Ebitda -6.31 = -2.50
6. ROIC - WACC (= -32.85)% = -12.50
7. RoE -251.8% = -2.50
8. Rev. Trend 98.37% = 7.38
9. EPS Trend 89.30% = 4.46

What is the price of ATEC shares?

As of October 21, 2025, the stock is trading at USD 15.50 with a total of 1,953,953 shares traded.
Over the past week, the price has changed by +17.07%, over one month by -0.64%, over three months by +50.41% and over the past year by +189.18%.

Is Alphatec Holdings a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Alphatec Holdings (NASDAQ:ATEC) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 37.70 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ATEC is around 14.80 USD . This means that ATEC is currently overvalued and has a potential downside of -4.52%.

Is ATEC a buy, sell or hold?

Alphatec Holdings has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy ATEC.
  • Strong Buy: 4
  • Buy: 5
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ATEC price?

Issuer Target Up/Down from current
Wallstreet Target Price 19.2 23.5%
Analysts Target Price 19.2 23.5%
ValueRay Target Price 16.4 6.1%

Last update: 2025-10-11 02:32

ATEC Fundamental Data Overview

Market Cap USD = 1.94b (1.94b USD * 1.0 USD.USD)
P/E Forward = 30.581
P/S = 2.8502
P/B = 85.6614
Beta = 1.056
Revenue TTM = 682.2m USD
EBIT TTM = -131.8m USD
EBITDA TTM = -68.1m USD
Long Term Debt = 552.0m USD (from longTermDebt, last quarter)
Short Term Debt = 8.43m USD (from shortTermDebt, last quarter)
Debt = 586.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 429.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.37b USD (1.94b + Debt 586.6m - CCE 157.1m)
Interest Coverage Ratio = -3.89 (Ebit TTM -131.8m / Interest Expense TTM 33.9m)
FCF Yield = -1.19% (FCF TTM -28.2m / Enterprise Value 2.37b)
FCF Margin = -4.13% (FCF TTM -28.2m / Revenue TTM 682.2m)
Net Margin = -24.33% (Net Income TTM -166.0m / Revenue TTM 682.2m)
Gross Margin = 68.81% ((Revenue TTM 682.2m - Cost of Revenue TTM 212.8m) / Revenue TTM)
Gross Margin QoQ = 69.58% (prev 68.56%)
Tobins Q-Ratio = 3.00 (Enterprise Value 2.37b / Total Assets 790.3m)
Interest Expense / Debt = 2.10% (Interest Expense 12.3m / Debt 586.6m)
Taxrate = 0.09% (-37.0k / -41.2m)
NOPAT = -131.7m (EBIT -131.8m * (1 - 0.09%)) [loss with tax shield]
Current Ratio = 2.88 (Total Current Assets 443.3m / Total Current Liabilities 154.2m)
Debt / Equity = 12.38 (Debt 586.6m / totalStockholderEquity, last quarter 47.4m)
Debt / EBITDA = -6.31 (negative EBITDA) (Net Debt 429.6m / EBITDA -68.1m)
Debt / FCF = -15.24 (negative FCF - burning cash) (Net Debt 429.6m / FCF TTM -28.2m)
Total Stockholder Equity = 65.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -21.00% (Net Income -166.0m / Total Assets 790.3m)
RoE = -251.8% (Net Income TTM -166.0m / Total Stockholder Equity 65.9m)
RoCE = -21.33% (EBIT -131.8m / Capital Employed (Equity 65.9m + L.T.Debt 552.0m))
RoIC = -24.75% (negative operating profit) (NOPAT -131.7m / Invested Capital 532.1m)
WACC = 8.10% (E(1.94b)/V(2.53b) * Re(9.91%) + D(586.6m)/V(2.53b) * Rd(2.10%) * (1-Tc(0.00)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.87%
Fair Price DCF = unknown (Cash Flow -28.2m)
EPS Correlation: 89.30 | EPS CAGR: 58.02% | SUE: 0.51 | # QB: 0
Revenue Correlation: 98.37 | Revenue CAGR: 30.18% | SUE: 2.87 | # QB: 1

Additional Sources for ATEC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle